Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–2 of 2 stories
Recent research identifies TRIB1AL as a potential target for steatotic liver disease through integrative genetic and liver transcriptomic analyses. This discovery could pave the way for new therapeutic strategies in managing this condition.
A recent case study highlights pseudohyponatremia in a patient with severe liver disease, shedding light on the complexities of electrolyte imbalances in this population. This finding may influence clinical approaches to managing sodium levels in patients with liver conditions.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.